Literature DB >> 23996203

Tissue-engineered mesh for pelvic floor reconstruction fabricated from silk fibroin scaffold with adipose-derived mesenchymal stem cells.

Qi Li1, Jianliu Wang, Haifeng Liu, Bing Xie, Lihui Wei.   

Abstract

A tissue-engineered mesh fabricated with adipose-derived mesenchymal stem cells (AD-MSCs) cultured on a silk fibroin scaffold is evaluated for use in female pelvic reconstruction. Thirty-five female Sprague Dawley rats were divided into four groups. Group A (n = 10) were implanted with polypropylene meshes, Group B (n = 10) with silk fibroin scaffolds and Group C (n = 10) with tissue-engineered meshes. Group D (n = 5) acted as the tissue control. The tissue-engineered mesh was produced as follows. AD-MSCs were obtained from adipose tissue of rats designated to Group C. The cells were seeded onto a silk fibroin scaffold, cultured and then observed by scanning electron microscopy (SEM). Histological studies of these meshes were performed at 4 and 12 weeks after implantation and mechanical testing was carried out on all groups before implantation and at 12 weeks after implantation. AD-MSCs displayed fibroblast-like shapes and were able to differentiate into adipocytes or fibroblasts. SEM observation showed that AD-MSCs proliferated and secreted a matrix onto the silk fibroin scaffolds. After implantation of the scaffolds into rats, histological analysis revealed better organized newly formed tissue in Group C than in controls. Group C also had a similar failure force (2.67 ± 0.15 vs 2.33 ± 0.38 N) and a higher Young's modulus (2.99 ± 0.19 vs 1.68 ± 0.20 MPa) than a normal vaginal wall, indicating the potential of this tissue-engineered approach. AD-MSCs were validated as seed cells for tissue engineering. The silk fibroin scaffold thus shows promise for application with AD-MSCs in the fabrication of tissue-engineered mesh with good biocompatibility and appropriate mechanical properties for pelvic floor reconstruction.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23996203     DOI: 10.1007/s00441-013-1719-2

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  7 in total

1.  Bioengineering Strategies to Treat Female Infertility.

Authors:  Che-Ying Kuo; Hannah Baker; Melissa H Fries; James J Yoo; Peter C W Kim; John P Fisher
Journal:  Tissue Eng Part B Rev       Date:  2017-02-03       Impact factor: 6.389

Review 2.  Textile Technologies and Tissue Engineering: A Path Toward Organ Weaving.

Authors:  Mohsen Akbari; Ali Tamayol; Sara Bagherifard; Ludovic Serex; Pooria Mostafalu; Negar Faramarzi; Mohammad Hossein Mohammadi; Ali Khademhosseini
Journal:  Adv Healthc Mater       Date:  2016-02-29       Impact factor: 9.933

Review 3.  Regenerative Medicine Approaches in Bioengineering Female Reproductive Tissues.

Authors:  Sivanandane Sittadjody; Tracy Criswell; John D Jackson; Anthony Atala; James J Yoo
Journal:  Reprod Sci       Date:  2021-04-20       Impact factor: 3.060

4.  Clinical application of a silk fibroin protein biologic scaffold for abdominal wall fascial reinforcement.

Authors:  Mark W Clemens; Susan Downey; Frank Agullo; Max R Lehfeldt; Gabriel M Kind; Humberto Palladino; Deirdre Marshall; Mark L Jewell; Anshu B Mathur; Bradley P Bengtson
Journal:  Plast Reconstr Surg Glob Open       Date:  2014-12-05

5.  Biocompatibility of polypropylene mesh scaffold with adipose-derived stem cells.

Authors:  Hui Cheng; Yanling Zhang; Bei Zhang; Jie Cheng; Weiqi Wang; Xin Tang; Peng Teng; Yanyu Li
Journal:  Exp Ther Med       Date:  2017-04-13       Impact factor: 2.447

Review 6.  Tissue engineering in female pelvic floor reconstruction.

Authors:  Xiaotong Wu; YuanYuan Jia; Xiuli Sun; Jianliu Wang
Journal:  Eng Life Sci       Date:  2020-04-14       Impact factor: 2.678

7.  MicroRNA-124-3p affects myogenic differentiation of adipose-derived stem cells by targeting Caveolin-1 during pelvic floor dysfunction in Sprague Dawley rats.

Authors:  Hao Chen; Zihao Li; Ming Lin; Xuling Lv; Jingping Wang; Qing Wei; Zikai Zhang; Liqun Li
Journal:  Ann Transl Med       Date:  2021-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.